Geron has 6 Phase 2 trials on going. Four with Imetelstat: Breast Cancer, Non-Small Cell Lung Cancer, Essential Thrombocythemia, and Multiple Meloma. These four will have results by the end of this year, Dec. 2012. Two trials with GRN1005: Breast Cancer with metastases to the brain and Non-small cell lung cancer with metastases to the brain. These two will have results by the end of the 2Q of 2013.
If the results are positive, showing efficacy of only 10% that would be great news. I think 15% is possible judging by the Phase I trials. On the four Phase II trials ending this year, the small cell lung cancer efficacy of 2 to 3 months would be great news. I put a big bet on Geron. If I'm right on the Imetelstats and they work I'll be rich, if I'm wrong I'll be working till I drop dead.
ACTC:
With Geron out of the stem cell business. I brought some ACTC. They have Phase 1/2 trials going on now. Stargardt's Macular Dystrophy & Dry Age-Related Macular Degeneration. Human embryonic stem cell are injected in the eye. If it works the patient's vision will improve. I have a good feeling about this company.
Both company's need money badly and soon.
Always remember you can lose all your money in any stock.
Good luck in this rigged casino,
No comments:
Post a Comment